论文部分内容阅读
同位素碘-~(131)Ⅰ(碘化钠溶液)口服治疗甲亢病是目前治疗甲亢的主要方法之一,其不足之处是甲状腺机能减退(甲低)的发生率逐年递增,如何有效地减少或避免甲低的发生是同位素碘-～(131)Ⅰ治疗甲亢要解决的重要课题。近5年来我们采用低剂量碘-(131)Ⅰ联合抗甲亢药物治疗甲亢,获随访125例报告如下。 1 资料 125例甲亢病人,男42例,女83例,年龄32～64岁,平均43.1岁,为我院门诊和住院病人,均经临床和核医学检查(包括甲状腺吸~(131)碘功能试验、甲状腺抑制试验、血清T_3、T_4、TSH、TM、TG、FT_3、
Oral isotope iodine - 131I (sodium iodide solution) oral treatment of hyperthyroidism is the treatment of hyperthyroidism is one of the main methods, the downside is the incidence of hypothyroidism (hypothyroidism) increased year by year, how to effectively reduce Or to avoid the occurrence of hypothyroidism is isotope iodine - 131 I treatment of hyperthyroidism to be solved an important issue. In the past five years, we used low-dose iodine - (131) Ⅰ combined with anti-hyperthyroidism treatment of hyperthyroidism, were followed up for 125 cases reported as follows. 1 Materials 125 cases of hyperthyroidism patients, 42 males and 83 females, aged 32 to 64 years old, an average of 43.1 years of age, for our hospital outpatient and inpatient, are clinically and nuclear medicine examination (including 131I iodine thyroid function Thyroid inhibition test, Serum T_3, T_4, TSH, TM, TG, FT_3,